A high frequency (about 60%) of ret rearrangements in papillary thyroid carcinomas of children exposed to radioactive fallout in Belarus after the Chernobyl accident, has been reported by three recent studies Ito et al., 1994; Klugbauer et al., 1995) . These studies suggested that the radiation exposure may be a direct inducer of activating rearrangements in the ret gene. In order to con®rm the postulated link between irradiation and the role of the ret protooncogene in thyroid tumorigenesis, we analysed for the presence of ret activating rearrangements using RT ± PCR, XL ± PCR, Southern blot and direct sequencing techniques, 39 human thyroid tumors (19 papillary carcinomas and 20 follicular adenomas), from patients who had received external radiation for benign or malignant conditions. As controls, we studied 39 spontaneous' tumors (20 papillary carcinomas and 19 follicular adenomas). Our data concerning the radiationassociated tumors, showed that: (1) the overall frequency of ret rearrangements was 84% in papillary carcinomas (16/19) and 45% (9/20) in follicular adenomas; (2) in contrast with the results obtained in the Chernobyl tumors, the most frequently observed chimeric gene was RET/PTC1 instead of the RET/PTC3 and (3) all the tumors were negative for RET/PTC2. In the`spontaneous' tumors, only the papillary carcinomas presented a ret rearrangement (15% : 3/20): 1 RET/PTC1, 1 RET/ PTC3 and 1 uncharacterized. In conclusion, our results con®rm the crucial role played by the ret proto-oncogene activating rearrangements in the development of radiation-associated thyroid tumors appearing after therapeutic or accidental ionizing irradiation, and show, for the ®rst time, the presence of RET/PTC genes in follicular adenomas appeared after external irradiation.
Introduction
In 1950, the ®rst epidemiologic study relating external beam radiation exposure and childhood thyroid cancer was published (Duy and Fitzgerald, 1950) . Since then, an increased incidence of thyroid tumors has been observed in populations including atomic bomb survivors (Wood et al., 1969) , inhabitants of regions aected by a thermonuclear test (Conard et al., 1970) , patients with a history of external radiation for benign or malignant conditions (Shore et al., 1985) , and most recently, in children contaminated in Ukraine and Belarus as a consequence of the Chernobyl accident (Kazakov et al., 1992) . In the latter case, most of the tumors appeared after a short latent period, and were papillary carcinomas which were assumed to be the consequence of the contamination of the exposed children by radioactive iodine isotopes. Indeed, it has been reported that in humans, external radiation increases the risk of development of benign and malignant thyroid tumors and that, following a dose of one Gy in childhood, 88% of thyroid carcinomas diagnosed in these patients can be attributed to radiation (Ron et al., 1995) . Moreover, in rodents, radiation has been a traditional experimental method of inducing thyroid tumors (Fraker, 1995; Lemoine et al., 1988; Shore et al., 1993) . However, little is known concerning the molecular mechanisms originating the radiation-associated tumorigenic process in the thyroid gland.
Studies from dierent laboratories have ®rmly established the involvement of six genes in thè spontaneous' epithelial thyroid tumorigenic process: ras, gsp, ret, trk, p53 and TSH-R (Parma et al., 1993; Russo et al., 1995; SaõÈ d et al., 1994) . Concerning thyroid tumors from patients with a history of external radiation for benign or malignant conditions, activating mutations in the ras and gsp genes have been described, and their frequency was similar to that observed in`spontaneous' tumors (Challeton et al., 1995; Wright et al., 1991) . Moreover, a recent study suggested that p53 gene point mutations may play a pathogenic role in some radiation-induced well dierentiated thyroid cancers, explaining the aggressiveness of some of these tumors (Fogelfeld et al., 1996) . In contrast with the data from Challeton et al. (1995) , in tumors arising in children after the Chernobyl accident Nikiforov et al. (1996) observed ras point mutations in 1/1 follicular carcinoma and in 3/7 follicular adenomas, but not in the 33 papillary carcinomas studied. These authors concluded that ras does not appear to be important in the development of the Chernobyl papillary carcinomas.
It has been suggested by three recent studies concerning small series of Chernobyl tumors, that the radiation exposure may be, with a high frequency (about 60%), a direct inducer of activating rearrangements in the ret gene Ito et al., 1994; Klugbauer et al., 1995) . The activating rearrangements were observed exclusively in papillary carcinomas, and this ®nding was in agreement with results of previous experiments showing that`in vitro' irradiation is able to originate ret rearrangements in human undierentiated thyroid carcinoma cells (Ito et al., 1993) .
The ret proto-oncogene, located on chromosome 10q11.2, encodes for a protein structurally related to transmembrane receptors with a tyrosine kinase domain (Takahashi and Cooper, 1987; Takahashi et al., 1988) , and recently Durbec et al. (1996) and Trupp et al. (1996) , showed that its putative ligand is the Glial-cell-line Derived Neurotrophic Factor (GDNF). The gene is expressed in a variety of neuronal cell lineages as well as in the kidney and enteric nervous system (Pachnis et al., 1993; Schuchardt et al., 1994) . The activated ret oncogene was ®rst isolated by the transfection of NIH3T3 cells with DNA from a human T cell lymphoma (Takahashi et al., 1985) . Germline point mutations of ret have been described in patients aicted by MEN 2A and MEN 2B syndromes or familial medullary thyroid carcinoma (FMTC), strongly suggesting an involvement of ret in the pathogenesis of these diseases (Donis-Keller et al., 1993; Eng et al., 1994; Mulligan et al., 1993) .
In papillary thyroid carcinomas (PTC) four oncogenically activated forms of the ret proto-oncogene have been identi®ed and designated RET/PTC1, RET/ PTC2, RET/PTC3 and recently RET/PTC4 (Bongarzone et al., 1993; Fugazzola et al., 1996; Grieco et al., 1990; Santoro et al., 1994) . All these activated forms of the proto-oncogene, are the consequence of speci®c oncogenic rearrangements fusioning the tyrosine kinase domain of ret with the 5' domain of dierent genes. RET/PTC1 is formed by an intrachromosomal rearrangement fusioning the ret tyrosine kinase domain to a gene designated H4 (D10S170), whose function is still unknown (Grieco et al., 1990) . In RET/ PTC2, the catalytic domain of ret is fused to the 5' terminal sequence of the gene located on chromosome 17 encoding the RIa regulatory subunit of protein kinase A (Bongarzone et al., 1993) , while RET/PTC3 is formed by the fusion of the tyrosine kinase domain of ret with another gene located in chromosome 10: ELE1, also designated Ret Fused Gene (RFG) Santoro et al., 1994) . Fugazzola et al. (1996) have recently described a new form of oncogenic rearrangement between ret and ELE1 : PTC4. This new chimeric gene was isolated in a post-Chernobyl thyroid tumor. All these oncogenic CO1{  PA2  BE3  PE4{  JE5  AU6{  AB7  PU8  MA9  RI10  FE11  ME12  DU13  GO14  BO15  VA16  DZ17  SO18  TS19  PL20{  SA21  BO22  BR23  PE24  AK25  LA26{  RE27  MA28  RI29  AB30  OF31  CA32  JA33  RO34  PA35  FA36  AU37  VE38  MA39   Male  Female  Female  Female  Male  Female  Female  Female  Female  Male  Male  Female  Male  Male  Male  Female  Female  Female  Male  Female  Male  Female  Female  Female  Female  Female  Female  Male  Female  Female  Male  Female  Male  Male  Male  Female  Female  Female  Male   3/ 19  5  47  20  34  25  38  24  22  23  28  28  22  18  20  50  38  46  36  42  53  30  33  46  33  18  38  34  18  25  21  29  39  27  21  34  47  27  31   PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC  PTC 
Dose received by the thyroid calculated according to Diallo et al. (1996) . *PTC: papillary thyroid carcinoma; Macr. Ad.: macrofollicular adenoma. Micr. Ad.: microfollicular adenoma. Mix. Ad.: mixed adenoma (samples from tumors with both macro-and microfollicular features). **RT ± PCR: reverse transcribed PCR; XL ± PCR: extra-long PCR.
# nd: not done. 7Underlined patients screened also for ras and gsp (Challeton et al., 1995; SuaÂ rez et al., 1991). {Samples positive for ras. {Samples positive for gsp forms of ret, seem to be speci®c of papillary carcinomas. However, the chimeric transcript of RET/PTC oncogene, has also been found in one study in follicular adenomas . Contrasting with the high and very similar frequency (about 60%) of activation observed in the Chernobyl tumors Ito et al., 1994; Klugbauer et al., 1995) , the frequency of ret activation in`spontaneous' thyroid tumors varies widely between dierent studies: from 2.5% to 34% Delvincourt et al., 1996; SaõÈ d et al., 1994; Santoro et al., 1992; Wajjwalku et al., 1992; Zou et al., 1994) . It has been postulated that this variation could be the result of the dierent geographical origins of populations studied, the age at tumor occurrence, or the sensitivity of the experimental methods used to detect the rearrangement.
With the aim of further investigating the postulated link between irradiation and the role of the ret protooncogene in thyroid tumorigenesis, we have screened both fresh and paran embedded material obtained from radiation-associated thyroid tumors other than post-Chernobyl samples. We have analysed for the presence of ret activating rearrangements 39 human thyroid tumors (19 papillary carcinomas and 20 follicular adenomas) which had developed in patients who had received external radiation therapy for benign or malignant conditions (Table 1) . As a control, we studied 39`spontaneous' thyroid tumors collected from patients without a history of therapeutic or accidental irradiation (20 papillary carcinomas and 19 follicular adenomas) ( Table 2 ). The ret activating rearrangements were screened using RT ± PCR, XL ± PCR, Southern blot and DNA-sequencing techniques.
Results
Presence of RET/PTC rearrangements in radiationassociated and`spontaneous' human thyroid tumors Thirty-nine tumors obtained from patients with a history of external radiation for benign or malignant conditions (20 follicular adenomas and 19 papillary carcinomas) (Table 1) , were examined for the presence of RET/PTC activating rearrangements, using the RT ± PCR and the XL ± PCR techniques.
Twelve cases of papillary carcinoma and 14 follicular adenomas were screened by RT ± PCR looking for the presence of RET/PTC one, two and three transcripts, using the primers described in Table  3 . RET/PTC1 transcripts were detected in 11/12 LA1{  SE2{  TA3  QU4  CH5  SE6  MA7{  FR8  BL9  SZ10  GA11  SE12{  PA13  MA14  BE15  BE16  NA17  GI18{  UR19  KR20  RO21  GR22{  FR23{  CO24{  MA25{  RO26  FA27  HE28{  OU29  AM30  FR31  JE32  AH33{  DE34  RE35  SA36  BR37{  TH38{  CA39   Male  Female  Female  Male  Female  Male  Female  Female  Female  Female  Female  Female  Female  Female  Female  Female  Male  Female  Male  Female  Female  Female  Female  Female  Female  Female  Female  Female  Female  Female  Female  Male  Male  Female  Male  Female  Female  Female  Female   22  15  30  39  32  75  46  27  44  39  30  9  47  51  20  57  13  28  55  13  41  26  58  22  12  28  43  29  46  35  31  51  61  29  69  64  33 papillary carcinomas and 4/14 adenomas, whereas only 2/12 carcinomas were positive for PTC3 (Table  1) . Interestingly, the two papillary carcinomas positive for PTC3, presented also PTC1 transcripts. All the tumors were negative for RET/PTC2. Figure 1 illustrates representative results obtained with RNAs extracted from paran-embedded positive tumor tissue. The PTC1 and PTC3 bands (231 and 242 bp respectively), were observed only after a second round of PCR, probably re¯ecting the fact that these RNAs were prepared from a small volume of sample ®xed in Bouin or Duboss. Moreover, in the two samples presenting both, PTC1 and PTC3 transcripts, the PTC3 band was weaker than the PTC1 band ( Figure  1 ). This observation suggests that the PTC1 type of rearrangement, may be the most common one in these cellular populations.
The XL ± PCR technique was also used to investigate the presence of RET/PTC one, two and three rearrangements in eight papillary carcinomas and 13 adenomas. Some of these tumors (Table 1) were also studied by RT ± PCR. Our data showed the presence of a RET/PTC1 rearrangement in 4/8 carcinomas and 6/13 adenomas con®rming the positive or negative results obtained by RT ± PCR (Table 1) . Only two papillary carcinomas were positive for the RET/PTC3 rearrangement. All the tumors were negative for PTC2. Some examples of RET/ PTC1 and RET/PTC3 rearrangements detected by XL ± PCR in positive tumors are shown in Figure  2a ,b. All the positive cases studied by RT ± PCR were con®rmed by sequencing the c-DNAs (data not shown). The sequences of the samples studied by XL ± PCR are now being carried out. The genomic fusion sequence of a`spontaneous' and a radiationassociated RET ± PTC3 positive tumors studied by XL ± PCR, are shown in Figure 3 .
For comparison, the presence of oncogenic RET/ PTC one, two and three rearrangements, was investigated by Southern blot and XL ± PCR techniques in the DNAs from 39`spontaneous' tumors (20 papillary carcinomas and 19 follicular adenomas). Some of the tumors were studied only by XL ± PCR (Table 2) . Only three carcinomas showed a RET/PTC rearrangement whereas the follicular adenomas were all negative. In the case of patient BL9, positive by both XL ± PCR and Southern (Figure 2a ,c), the chimeric gene was identi®ed as RET/PTC1. In the case of patient SE2, the rearrangement was detected only by XL ± PCR using the RET/PTC3 primers ( Figure 2b) . Finally, the tumor of patient CH5 was one of the previously studied papillary carcinomas found positive by Southern blot (Figure 2c ) for a ret rearrangement , and no more material was available to identify it by RT ± PCR or XL ± PCR. 5'-CTG TCC TCT TCT CCT TCA TC-3' 5'-TGC AGG CCC CAT ACA ATT TG-3' 5'-TCC ATG GAG AAC CAG GTC TCC-3' 5'-CTT TCA GCA TCT TCA CGG-3' 5'-TAC CCT GCT CTG CCT TTC AGA TGG-3' 5'-ATG GAC AAG TTC CAA TGT GC-3' 5'-AGT TCT TCC GAG GGA ATT CC-3' exon 11, nt 1853 ± 1872 exon 13, nt 2295 ± 2314 exon 11, nt 2026 ± 2046 exon 12, nt 485 ± 493 (Grieco et al., 1990) exon 12, nt 2381 ± 2404 (Smanik et al., 1995) intron 11 (Smanik et al., 1995) exon 12, nt 2300 ± 2319 (Smanik et al., 1995) H4 primers: RET/PTC1 (outer forward) PTCI (in-nested) H1b (forward)
5'-ATT GTC ATC TCG CCG TTC-3' 5'-AGA TAG AGC TGG AGA CCT AC-3' 5'-AGC GCC AGC GAG AGC GAC ACG-3' H4 exon 1, nt 196 ± 213 (Grieco et al., 1990) H4 exon 1, nt 272 ± 291 H4 exon 1, nt 61 ± 81 (Smanik et al., 1995) RIa primers: RET/PTC2 (outer forward) PTC II (in-nested forward)
5'-TAT CGC AGG AGA GAC TGT GAT-3' 5'-AGG GAG CTT TGG AGA ACT TG-3'
RIa, nt 483 ± 503 (Bongarzone et al., 1993) RIa, nt 600 ± 619 ELE1 primers: Our results show that the overall frequency of ret rearrangements is highly signi®cantly dierent between radiation-associated (25/39 : 64%), and`spontaneous' thyroid tumors (3/39 : 8%). If the papillary carcinomas and follicular adenomas are considered separately, this dierence remains important. Indeed, while in the radiation-associated carcinomas the frequency is 84% (16/19), in the`spontaneous' ones it is 15% (3/20). The frequency of ret rearrangements is 45% (9/20) in the radiation-associated follicular adenomas, whereas all the`spontaneous' samples are negative. The most frequently detected RET/PTC gene in our radiationassociated tumors is PTC1. This rearrangement is present in 23 of the 25 positive tumors, whereas PTC3 was found only in four carcinomas: in two tumors alone and in the other two, together with PTC1 (Table 1) .
Relationship between RET activation, age and radiationassociated thyroid tumorigenesis
To investigate the eventual correlation between ret activation, age of the patient and development of thyroid tumorigenesis after external radiation for benign or malignant conditions, we analysed comparatively the following parameters: age of the patients at irradiation, latency until tumor diagnosis, age at diagnosis of the thyroid tumor and presence or absence of activating rearrangements.
Considering the age at irradiation and the latency period of the tumors, the patients were arranged in groups with age increasing by 4 yrs (data not shown).
As shown in Table 1 , the majority of our patients (29/39) were irradiated before 15 yrs of age. For each one of the three groups (age 0 ± 4, 5 ± 9 and 10 ± 14 at irradiation) in which these patients were divided, we observed 64% (9/14), 33% (3/9) and 83% (5/6) of ret rearrangements respectively, with an average frequency of 59% (17/29). The number of patients irradiated after 15 yrs of age being small or null in each 4 yrs range, we calculated their frequency of ret rearrangements as a single group. Eight of these ten samples presented a rearrangement (80%) ( Table 1 ). There is no statistical dierence between the overall frequencies of ret rearrangements, observed in the patients irradiated before or after 15 yrs of age. The latent period of our radiation-associated tumors varies from 3 to 35 yrs, with a signi®cant peak occurring around two age ranges: 15 ± 19 and 20 ± 24 yrs (Table 1 ). This distribution is independent of the histologic type of the tumor or the age at the moment of irradiation (Table 1 ). In the 15 ± 19 age range, the frequency of ret rearrangements was 71% (5/7) for both papillary carcinomas and adenomas, whereas in the 20 ± 24 yrs range it was 80% (4/5) and 67% (4/6) for the malignant or benign tumors respectively (Table  1) . If we pool the frequencies of the two groups constituting the peak, the average frequency of rearrangements is 72% (18/25). Again, in each 4 yrs age range including tumors appearing before 14 or after 25 yrs of latency, the number of samples is very small. If we consider them as two independent groups one from 0 to 14 yrs and the other from 25 to 39 yrs, the frequencies of rearrangements are 62% (5/8) and 33% (2/6), respectively (Table 1) . No follicular adenomas were positive in the two latter groups and no signi®cant dierence exist between the frequencies of the dierent groups.
Looking for an eventual correlation between the age of the patients at diagnosis of the thyroid tumor and the presence of ret activating rearrangements, we established three comparable groups of 13, 14 and 12 tumors, comprised in three age ranges: 5 ± 24, 25 ± 35 and 36 ± 60 yrs. We found 69%, 50% and 83% of ret rearrangements respectively (Table 4 ). These frequencies are not signi®cantly dierent. Having only three positive cases in the`spontaneous' group, the eventual correlation between age of the patients at diagnosis and RET/PTC presence was not calculated.
Finally, when we also divided our`spontaneous' tumors into three groups of 14, 12 and 13 samples included in three age ranges of 5 ± 29, 30 ± 45 and 46 ± 75 yrs respectively, we did not ®nd any dierence in the frequency of ret rearrangements (data not shown). Indeed, only one tumor was positive in each age range, the overall frequency being 7 ± 8% (1/14, 1/12 and 1/13 respectively).
Discussion
In order to have more conclusive data about an eventual key role played by the ret gene in radiationassociated thyroid tumorigenesis, we have studied 39 cases of malignant and benign thyroid tumors collected at the Institut Gustave Roussy (Villejuif, France), from patients with a history of external radiation at dierent ages (predominantly in childhood) for benign or malignant conditions. The results obtained with this series of tumors, were compared with data obtained screening 39 malignant and benign`spontaneous' thyroid tumors from children and adult patients, without a previous history of irradiation.
In our study, carried out using the RT-PCR, XL ± PCR and Southern blot techniques, 25/39 (64%) of the radiation-associated tumors showed a RET/PTC1 or RET/PTC3 chimeric genes, whereas only 3/39 (8%) of the`spontaneous' tumors were positive. In the papers published by Fugazzola et al. (1995) , Ito et al. (1994) and Klugbauer et al. (1995) concerning post-Chernobyl tumors, only papillary carcinomas were screened. In our study, the overall frequency of ret rearrangements in the radiationassociated papillary carcinomas is signi®cantly higher (84% : 16/19) than in the`spontaneous' ones (15% : 3/20), and slightly but not signi®cantly higher than that observed in the Chernobyl tumors (Table  5 ). Concerning the`spontaneous' papillary carcinomas, our present and previous results as well as those obtained by Delvincourt et al. (1996) studying homogeneous French populations from the Champagne-Ardennes region, show as in
ret ret a b Figure 3 Sequence analysis of XL ± PCR ampli®ed DNA from: (a) a`spontaneous' thyroid papillary carcinoma (patient SE2) and (b) a radiation-associated thyroid papillary carcinoma (patient RI10) (XL ± PCR in Figure 2b ). In both cases the rearrangement detected correspond to a RET/PTC3 chimeric gene. The arrows indicate the fusion point at positions 1085 and 685 (Smanik et al., 1995) in the ret and ELE-1 genes, respectively Ret oncogene in radiation-associated thyroid tumors A Bounacer et al other non-italian populations, a lower overall frequency of ret activation when compared to data from Bongarzone et al. (1989 Bongarzone et al. ( , 1994 and studying tumors from Italian patients (Table 5) . It is interesting to point out the presence, in our benign tumors associated with a radiation history, of RET/PTC1 rearrangements with a relative high frequency: 45% (9/20). The presence of RET/PTC transcripts in`spontaneous' follicular adenomas, but with a lower frequency (about 20% : 4/19), was previously seen only by Ishizaka et al. (1991) using the RT ± PCR technique (Table 5) . However, these authors found that dierent transcripts obtained from the same tumor were not always positive, suggesting the presence in the same sample of heterogeneous cellular populations both positive or negative for RET/ PTC. In our study, none of the 20 radiation-associated follicular adenomas studied, presented malignant features. In seven of them, data (positive or negative) were in agreement using both RT ± or XL ± PCR techniques. In the other 13 tumors only one of the techniques was used. Figure 4 , illustrates the histological appearance of representative cases of follicular adenomas (patients PL20 and SA21), and in Figure 2a are presented the ret rearrangements detected in these samples (PTC1 in all the cases).
Epidemiologic studies have shown that external radiation during childhood, increases the risk of subsequent development of papillary carcinoma and/ or follicular adenoma (Ron et al., 1995) . The detection of RET/PTC rearrangements in follicular adenomas occurring after external radiation, similar to those observed in radiation-associated papillary carcinomas, indicate that ret is a common target for radiation, playing a crucial role in the pathogenesis of both types of tumors. It also suggests that other genetic abnormalities will participate, in the irradiated patients, in the mechanism leading to the development of adenomas or carcinomas.
The most frequent ret chimeric gene detected by us using both RT ± and/or XL ± PCR, has been PTC1 (23/25 positives), PTC3 being present in only four tumors: in two cases alone and in two others, together with PTC1. These results are in contrast with data obtained in the post-Chernobyl tumors, in which PTC3 was the most frequent rearrangement Klugbauer et al., 1995) . Little is known about the preferential damage of ret by ionizing radiation and we do not know the reason why in our tumors the most common rearrangement is PTC1 and not PTC3. Tumors from children contaminated as a consequence of the Chernobyl accident, appeared after a short latent period and were assumed to be due to radioactive iodine isotopes, while the majority of our tumors as found in other series of radiation-associated thyroid tumors (Shore, 1992; Shore et al., 1993) , occurred at least 10 yrs after the external radiation. The number of early occurring tumors diagnosed after the Chernobyl accident is larger than in our series. It may be explained by the larger number of contaminated children in Ukraine and Belarus, compared to the number of children treated at the Gustave Roussy Institut for a thyroid radiation-associated tumor. We can imagine that the dierent types of ret rearrangements predominantly detected in Chernobyl tumors and in our series, may be due to the fact that RET/ PTC3 rearrangements may originate aggressive tumors with a short latency period, while RET/PTC1 rearrangements may give rise to slow growing tumors diagnosed after long periods of time. Alternatively, we cannot exclude other possibilities such as dierent genetic backgrounds or nutritional dierences (i.e. iodine intake), between the two populations. We have never observed in our tumors the PTC2 rearrangement, which was described among the Chernobyl tumors, in only one sample in one study . The data showing the predominant presence of PTC1 or PTC3 rearrangements, suggest that preferential intrachromosomal damage of ret occurs after external therapeutic or accidental ionizing radiation. It is, indeed, a classical equilibrated rearrangement found after cell irradiation. Concerning the samples presenting both PTC1 and PTC3 transcripts, work is in progress to establish whether or not these tumors are polyclonal.
Our results suggest that, at least in our patients with thyroid tumors supposed to be the consequence of an external irradiation treatment for benign or malignant conditions, the frequency of the ret protooncogene activation might not be related to the age at irradiation or diagnosis. Moreover, the age at irradiation does not seem important for determining the histologic type of the tumor. Interestingly, all the positive adenomas are found in the 15 ± 19/20 ± 24 year range of tumor latency, independently of the age at the moment of irradiation (Table 1) , and the higher number of ret rearrangements were detected in tumors with a latency period shorter than 25 yrs (Table 1) . Finally, there is also no relationship between the disease for which the patient(s) had been irradiated, the estimated radiation dose received by the thyroid and the presence or absence of RET/PTC chimeric genes (Table 1) .
Little is known about the mechanism of damage of ret by ionizing radiation. The only studies characterizing the nucleotide sequence surrounding the breakpoint in the chimeric genes, have been carried out by Grieco et al. (1990) and Smanik et al. (1995) , but with genetic material from`spontaneous' tumors. These papers outlined that, at the genomic level, each ret rearrangement was dierent from the other suggesting a sort of genomic ®nger printing for each tumor. Smanik et al. (1995) , showed that in the dierent tumors studied, the break-points occurred at sites of two or three nucleotide matches between the contributing ret and H4 or ELE1 germline sequences. However, the signi®cance of this result in the rearrangement process after radiation is unknown, mainly because of the small number of tumors studied and because they were all`spontaneous' tumors. Whether or not the same type of rearrangement occurs in radiation-associated tumors or if in these type of tumors there is participation at the fusion point of recombination-speci®c sequence elements (i.e. Alu sequences, palindromic or alternative purinepyrimidine sequences or A-T rich regions) as seen for dierent physical or chemical carcinogenic agents (Michelin et al., 1993; Stary et al., 1992; StoppaLyonnet et al., 1990) , needs to be studied. The XL ± PCR technique will be a useful tool to obtain this goal. Indeed, surprisingly, as illustrated in Figure 3 , preliminary results using this technique show a similar nucleotide sequence surrounding the RET/PTC3 break-point in one`spontaneous' and one radiationassociated samples of our series. Whether or not this is a fortuitous ®nding, will be answered by a comparative study of other break-point sequences present in radiation-associated and`spontaneous' RET/PTC positive tumors.
Twenty-eight of the radiation-associated tumors and all the`spontaneous' tumors studied in the present paper (39), were also previously screened for the presence of ras and/or gsp mutations (Challeton et al., 1995; SaõÈ d et al., 1994) . Among the radiationassociated tumors four were positive for ras, one for gsp and 18 presented ret rearrangements (Table 1) , whereas among the`spontaneous' tumors, ten were positive for ras, three for gsp and three presented ret rearrangements ( Table 2 ). The overall frequencies of ras, gsp and ret alterations in the radiation-associated tumors were 14%, 3% and 64% respectively, while in the`spontaneous' samples they were 25%, 7% and 8% respectively. Two of the four ras radiation-associated positive samples (patients PE4 and PL20) and the gsp positive one, presented simultaneously a PTC1 rearrangement (Table 1) . Among the ras and gsp positive`spontaneous' tumors, only the tumor of patient SE2 showed simultaneously, a ras mutation and a PTC3 rearrangement (Table 2) . We have previously shown the simultaneous presence of two dierent genetic alterations in another series of spontaneous' thyroid tumors studied by us: ras and trk and ras and gsp or TSHR (Russo et al., 1995) . It is not possible at present to say which genetic alteration occurred ®rst, in our`spontaneous' or radiation-associated tumors, or to speculate about an eventual mechanism of cooperation between the altered genes. However, the low number of ras, gsp or ret positive tumors which presented in our radiationassociated or`spontaneous' series another genetic alteration (3/23 and 1/16 respectively), plead in favor of an alternative role of these genes in the tumorigenic process.
In conclusion, taken together these data: (1) show as previously communicated (Challeton et al., 1995) , that there is not a signi®cant dierence in the frequency of activation of ras and gsp proto-oncogenes, between radiation-associated and`spontaneous' thyroid tumors (P=0.28 and 0.86 respectively by the chi-square test) and (2) they con®rm the relevant role played by ret in the development of radiation-associated thyroid tumors originated after therapeutic radiation or the atomic accident of Chernobyl (our present paper and Fugazzola et al., 1995; Ito et al., 1994 and Klugbauer et al., 1995) (Table 5) . Finally, this is the ®rst demonstration of the presence of ret activating rearrangements in radiation-associated follicular adenomas.
It will be interesting to determine: (1) whether or not in the radiation-associated tumors negative for ret, there exists another activated oncogene of the tyrosine protein kinases family (i.e. trk or met); (2) the nature of the sequences involved, after irradiation, in the formation of the break-points in each of the RET/ PTC chimeric genes and (3) why the most frequent ret rearrangement is not the same in thyroid tumors originated by therapeutic external or accidental atomic ionizing irradiation.
Materials and methods

Thyroid tumors
Tumors were collected at the Institute Gustave Roussy (Villejuif, France) and were histologically classi®ed according to the WHO recommendations (Hedinger et al., 1989) . A total of 39 tumors obtained from patients with a history of external irradiation for benign or malignant conditions, were examined: 20 follicular adenomas and 19 papillary carcinomas (Table 1) . Several characteristics of these tumors, allow their classi®cation as radiation-associated tumors (Shore, 1992) : (1) the estimated dose received by the thyroid was one Gy or more; (2) a majority of patients (29/39) have been irradiated at a young age (less than 15 yrs-old) and 19 developed tumors before the age of 30; (3) most of the tumors appeared 10 yrs or more after irradiation; (4) a majority of the patients (24/39) were females and (5) all the thyroid carcinomas were of the papillary histologic type. As controls we studied 39`spontaneous' human thyroid tumors collected from patients without any history of head, neck or chest irradiation: 19 follicular adenomas and 20 papillary carcinomas ( Table 2) .
The doses received by the thyroid have been calculated by us, acccording to Diallo et al. (1996) , only for the benign or malignant conditions treated at the Gustave Roussy Institut. Indeed, for 12/39 of our patients treated for their ®rst benign or malignant condition in other centers, the exact irradiation protocoles were not available (Table 1) .
RNA extraction from Duboss or Bouin ®xed and frozen thyroid tumor samples
RNA isolation from paran-embedded tissue samples was performed according to a previously described procedure (Jackson et al., 1989; Viglietto et al., 1995) , modi®ed by us. Brie¯y, two 20 mm tissue sections were cut from blocks of paran embedded tumor tissue and deparanised in two serial washes of 200 ml of xylene in 0.5 ml tubes. After centrifugation (12 000 g for 15 min at +48C), the pellet was washed twice with 200 ml of ethanol and dried. The pellet was resuspended in 100 ml of 50 mM Tris pH 8.6, 1 mM EDTA, 0.5% Tween, 80 U rRNasin Ribonuclease Inhibitor (Promega), 10 U RQ1 RNase free DNase (Promega) and 1 M KCl containing 0.3 mg/ml proteinase K (Merck), and incubated for 3 h at 378C and 10 min at 958C. After centrifugation (12 000 g for 15 min at +48C), the supernatant was transferred to a 0.5 ml tube and precipitated at 7208C overnight with 1 : 10 volume of 3 M sodium acetate and three volumes of ethanol. After centrifugation, the pellet was washed with 70% ethanol, air-dried and resuspended in 40 ml of sterilized water.
Total RNA was extracted from frozen fresh tissues using the RNA B TM technique (Bioprobe systems), following the manufacturer's instructions. Aliquots of isolated RNAs were analysed for their quality by agarose gel electrophoresis.
RT ± PCR method for detecting RET/PTC oncogenes
The reverse transcription reaction was performed on half the volume of RNA extracted from paran-embedded tissue extracts (18 ml) or 1.5 mg of total RNA from fresh tissue extracts. The RNA was reverse transcribed by incubation for 1 h at 378C in a ®nal volume of 40 ml containing 1000 U MMLV reverse transcriptase (Gibco BRL), 16RT buer (50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl 2 ), 1 mM of each dNTP (Pharmacia), 4 mM DTT (Gibco BRL), 1 U/ml rRNasin Ribonuclease Inhibitor (Promega) and 500 ng of random hexamers (Pharmacia). The reaction was stopped by incubation for 5 min at 958C. One fourth of the cDNA (10 ml), was used for PCR ampli®cation with outer primers. For the paranembedded tissue extracts, a second round of PCR was done with nested primers using 1 : 10 of the ®rst round PCR product.
The PCR ampli®cations were performed, using an automatic thermocycler (Perkin Elmer), in the presence of 2 U of Taq polymerase (Ampli Taq, Perkin-Elmer Cetus), 30 pmol of each sense and antisense primers, 16 reaction buer (10 mM Tris-HCl pH 8.3, 5 mM KCl, 0.01% gelatine), 250 mM of each dNTP and 1.5 mM MgCl 2 in a total volume of 50 ml. After one cycle at 948C for 2 min, 30 cycles of denaturation, annealing and extension were performed at 948C (30 s), 608C (1 min) and 728C (1 min) respectively. After 10 min at 728C to ensure that the ®nal extension step was complete, aliquots (10 ml) of the products of the reaction were analysed by electrophoresis through a 2% agarose gel.
PCR primer sequences used in this study are given in Table 3 .
DNA extraction from tissues
The DNA was extracted from fresh tissues (frozen immediately after surgery in liquid nitrogen and stored at 7708C until analysis) or from paran-embedded tissues (®xed in 10% buered formalin, Bouin or Duboss ®xatives), as described by SuaÂ rez et al. (1990 SuaÂ rez et al. ( , 1991 .
XL ± PCR of RET/PTC1, 2 and 3 chimeric introns
Ampli®cation of the RET/PTC chimeric introns from radiation-associated and`spontaneous' thyroid tumors, was carried out using the XL ± PCR kit (Perkin Elmer), according to the manufacturer's protocol. The amplification protocols were:
(a) PTC1 oncogene: an initial ampli®cation of the tumor DNA was carried out using a forward primer corresponding to H4 exon 1 (primer H1b, Smanik et al., 1995) and a reverse primer corresponding to c-ret exon 12 (primer R1b, Smanik et al., 1995) with the following cycling conditions: one cycle of 938C, 1 min; 16 cycles of 938C, 1 min; 658C, 10 min followed by 12 cycles where the 658C step was extended 15 s/cycle. The product of ampli®cation (5 ml) was used as template for a second round of ampli®cation using the nested primers PTCI (H4, Klugbauer et al., 1995) and R2 (c-ret intron 11, Smanik et al., 1995) and the same cycling conditions, with an annealing/extension temperature of 628C.
(b) PTC2 oncogene: a ®rst round of PCR of the tumoral DNA was carried out using a forward primer RET/PTC2 (RI a, Bongarzone et al., 1993) and a reverse primer retc2 (c-ret exon 13, Klugbauer et al., 1995) with the following cycling conditions: one cycle of 928C, 1 min; 16 cycles of 928C, 1 min; 608C, 10 min followed by 12 cycles where the 608C step was extended 15 s/cycle. The product of ampli®cation (5 ml) was ampli®ed again using the nested primers PTC II (RIa, Klugbauer et al., 1995) and R1b (cret, Smanik et al., 1995) and the same cycling conditions, with an annealing/extension temperature of 658C.
(c) PTC3 oncogene: the RET/PTC3 intron was also ampli®ed using the XL ± PCR technique. A ®rst round of PCR was done using the forward primer PTCIII (ELE1; Klugbauer et al., 1995) and the reverse primer R1 (c-ret exon 12, Smanik et al., 1995) . The following temperature cycling conditions were used: one cycle of 928C, 2 min; 16 cycles of 928C, 1 min; 558C 10 min followed by 12 cycles where the 558C step was extended 15 s/cycle. The product of ampli®cation (5 ml) was ampli®ed again with the nested forward and reverse primers: E1 (ELE1, Smanik et al., 1995) and R2 (c-ret intron 11, Smanik et al., 1995) respectively, and the same cycling conditions.
The following reaction buer was used for all the ampli®cation reactions: 16XL buer II (Perkin Elmer), 1.1 mM Mg (OAC) 2 , 0.2 mM dNTP, 0.5 ± 1.5 mM primers and 0.02 U/ml XL Taq polymerase (Perkin Elmer).
PCR primer sequences are given in Table 3 .
Southern blot analysis
Procedures for digestion of cellular DNAs (20 mg) with restriction endonucleases (EcoRI 100U), electrophoresis in agarose gels (0.8 ± 1%), transfer to nitrocellulose ®lters, and hybridization with a 1.0 Kbp BamHI-BglII ret speci®c probe, were performed as previously described .
DNA sequence analysis
Direct sequencing of the ampli®ed DNA fragments was carried out by the dideoxy-nucleotide method (Sanger et al., 1977) with [g-33 P]ATP, using the double strand DNA cycle sequencing system Kit (BRL, Life Technologies) and the same primers as those employed for the ampli®cation, following the manufacturer's conditions. The reaction mixtures were then resolved on standard 8% acrylamide sequencing gels. Following electrophoresis, gels were dried and autoradiographed with X-ray ®lm overnight.
